AsedaSciences and Clyde Biosciences Announce Commercial Agreement to Integrate Human-Relevant Cardiotoxicity Screening
Agreement integrates Clyde Biosciences' human-relevant, CellOPTIQ cardiotoxicity screen for chemical safety assessment into AsedaSciences 3RnD Platform SCHINDELLEGI, SCHWYZ, SWITZERLAND, January 27, 2026 /EINPresswire.com/ -- AsedaSciences®, …